PREVAIL is a clinical study to learn more about the effect of felzartamab on proteinuria
(too much protein in the urine) and the kidneys’ ability to filter blood in adults with IgAN.
To learn more about the PREVAIL study, please visit TrialLink.com or clinicaltrials.gov.
Not Currently Recruiting
